{"id":330533,"date":"2024-09-10T18:30:08","date_gmt":"2024-09-10T13:00:08","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=330533"},"modified":"2024-09-10T17:54:24","modified_gmt":"2024-09-10T12:24:24","slug":"khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/","title":{"rendered":"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc."},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"text-align: center; font-size: 16.0pt; font-weight: bold; margin-bottom: 3%;\">DEAL DETAILS<\/p>\n<p style=\"font-weight: bold; margin-bottom: 3%;\">Zydus Lifesciences Limited |Acquisition of 50% equity stake in Sterling Biotech<\/p>\n<p style=\"margin-bottom: 3%;\">Khaitan &amp; Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc. a Temasek portfolio company, to enter into fermentation-based protein business for a total consideration of INR 550 crores subject to certain adjustments with respect to cash and debt (including debt like items) as mentioned in the definitive agreements.<\/p>\n<p style=\"margin-bottom: 3%;\">Post this transaction, Sterling Biotech has become a 50:50 Joint Venture with equal representation on the Board.<\/p>\n<p style=\"margin-bottom: 3%;\">The deal was led by Bhavik Narsana (Partner) along with Nirav Punjani (Principal Associate) and Pragya Mishra (Associate) along with Zydus legal team lead by Mukund Thakkar (Sr. VP Legal), Kalpit Lodha (General Manager) and Randall Williams (Deputy Manager).<\/p>\n<p style=\"margin-bottom: 3%;\">Corporate: Abheepsita Purkayastha (Associate), Niharika Jain (Associate) and Nishant Sharma (Associate);<\/p>\n<p style=\"margin-bottom: 3%;\">Banking and Finance Team: Kumar Saurabh Singh (Partner), Ashwij Ramaiah (Principal Associate), Aaryan Mohan (Associate), Akash Mukherjee (Associate), Kartikey G (Associate) and Saumya Agarwal (Associate);<\/p>\n<p style=\"margin-bottom: 3%;\">Real Estate: Amit Wadhwani (Partner), Agarwal Rahul (Senior Associate) and Karan Thakkar (Associate);<\/p>\n<p style=\"margin-bottom: 3%;\">Litigation: Kingshuk Banerjee (Partner), Arnav Mohanty (Principal Associate) and Shayan Dasgupta (Principal Associate);<\/p>\n<p style=\"margin-bottom: 3%;\">Employment Law: Deepak Kumar (Partner), Archika Dudhwewala (senior Associate) and Sidheswar Sahoo (Associate);<\/p>\n<p style=\"margin-bottom: 3%;\">Intellectual Property: Nishad Nadkarni (Partner) and Riya Karkera (Associate).<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p><i>Khaitan &#038; Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary<\/i><\/p>\n","protected":false},"author":8808,"featured_media":330541,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[6791,72978,72977,72979,72976],"class_list":["post-330533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-khaitan-co","tag-perfect-day-inc","tag-sterling-biotech","tag-temasek-portfolio-company","tag-zydus-lifesciences-limited"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.4 (Yoast SEO v26.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc. | SCC Times<\/title>\n<meta name=\"description\" content=\"Khaitan &amp; Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc.\" \/>\n<meta property=\"og:description\" content=\"Khaitan &amp; Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-10T13:00:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bhumika Indulia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bhumika Indulia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/\",\"name\":\"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc. | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp\",\"datePublished\":\"2024-09-10T13:00:08+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\"},\"description\":\"Khaitan & Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp\",\"width\":886,\"height\":590,\"caption\":\"Zydus Lifesciences Limited\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\",\"name\":\"Bhumika Indulia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"caption\":\"Bhumika Indulia\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc. | SCC Times","description":"Khaitan & Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/","og_locale":"en_US","og_type":"article","og_title":"Khaitan & Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc.","og_description":"Khaitan & Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary","og_url":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2024-09-10T13:00:08+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.jpg","type":"image\/jpeg"}],"author":"Bhumika Indulia","twitter_card":"summary_large_image","twitter_title":"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc.","twitter_misc":{"Written by":"Bhumika Indulia","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/","url":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/","name":"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc. | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp","datePublished":"2024-09-10T13:00:08+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a"},"description":"Khaitan & Co advised Zydus Lifesciences Limited (Zydus) in relation to acquisition of 50% equity stake through its wholly owned subsidiary","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp","width":886,"height":590,"caption":"Zydus Lifesciences Limited"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/10\/khaitan-co-advises-zydus-lifesciences-limited-in-relation-to-acquisition-of-50-equity-stake-through-its-wholly-owned-subsidiary-in-sterling-biotech-from-perfect-day-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Khaitan &amp; Co advises Zydus Lifesciences Limited in relation to acquisition of 50% equity stake through its wholly owned subsidiary, in Sterling Biotech from Perfect Day Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a","name":"Bhumika Indulia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","caption":"Bhumika Indulia"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Zydus-Lifesciences-Limited.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":283450,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","url_meta":{"origin":330533,"position":0},"title":"Khaitan &amp; Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited","author":"Bhumika Indulia","date":"February 8, 2023","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited NO HEADINGS DETAILS 1. Sector Pharmaceutical Industry 2. Announcement Date 17-Jan-2023 3. Completion Date 17-Jan-2023 4. Name of Client Eris Lifesciences Limited Eris Lifesciences Ltd is a publicly listed Indian\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":287398,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/03\/21\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-dr-reddys-laboratories-limited\/","url_meta":{"origin":330533,"position":1},"title":"Khaitan &amp; Co advises Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy&#8217;s Laboratories Limited","author":"Bhumika Indulia","date":"March 21, 2023","format":false,"excerpt":"Khaitan & Co has advised Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy's Laboratories Limited for a total consideration of INR 275 crores. The acquisition helps augment and expand the dermatology business of Eris Lifesciences in India. The team assisted in drafting,\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":368864,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","url_meta":{"origin":330533,"position":2},"title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","author":"Editor","date":"December 5, 2025","format":false,"excerpt":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals, making it a wholly owned subsidiary.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Swiss Parenterals acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":266039,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/04\/27\/khaitan-co-advised-cpc-diagnostics-private-limited-on-acquisition-of-weldon-biotech\/","url_meta":{"origin":330533,"position":3},"title":"Khaitan &#038; Co advised CPC Diagnostics Private Limited on Acquisition of Weldon Biotech","author":"Bhumika Indulia","date":"April 27, 2022","format":false,"excerpt":"Khaitan & Co advised CPC Diagnostics Private Limited - Acquisition of Weldon Biotech. NO HEADINGS DETAILS 1. Sector \u00a0Medical device 2. Completion Date 12-Apr-2022 3. Name of Client CPC Diagnostics Private Limited 4. Buyer Details CPC Diagnostics Private Limited | India 5. Seller Details Weldon Biotech (India) Private Limited and\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-202.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-202.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-202.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-202.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/04\/MicrosoftTeams-image-202.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":369143,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/08\/cam-advises-swiss-parenterals-30-percent-stake-acquisition-eris-lifesciences-2025\/","url_meta":{"origin":330533,"position":4},"title":"Cyril Amarchand Mangaldas advises Swiss Parenterals Limited in acquisition of its 30% stake by Eris Lifesciences Limited","author":"Editor","date":"December 8, 2025","format":false,"excerpt":"Cyril Amarchand Mangaldas advised Swiss Parenterals Limited and its promoter on the sale of the remaining 30% stake to Eris Lifesciences Limited through a preferential allotment deal worth \u20b9423.30 crore.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Swiss Parenterals Eris Lifesciences acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":317745,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/03\/19\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-the-branded-formulations-business-of-biocon-biologics-limited-in-india\/","url_meta":{"origin":330533,"position":5},"title":"Khaitan &amp; Co advises Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"March 19, 2024","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Acquisition of the Indian branded formulations business of Biocon Biologics Limited Khaitan & Co advised Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India for a total consideration of INR 1,242 Crores. The acquisition helps augment\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/330533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/8808"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=330533"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/330533\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/330541"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=330533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=330533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=330533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}